Zymeworks Inc. Files 8-K Report
Ticker: ZYME · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1937653
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Zymeworks filed an 8-K today, check for 'Other Events' details.
AI Summary
On June 10, 2024, Zymeworks Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." Specific details regarding the nature of these events, including any financial implications or new developments, are not elaborated upon in the provided text.
Why It Matters
This filing signals that Zymeworks Inc. has made a regulatory disclosure. Investors and stakeholders should review the full report for details on any significant events that may impact the company.
Risk Assessment
Risk Level: low — The filing is a standard regulatory disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Zymeworks Inc. (company) — Registrant
- June 10, 2024 (date) — Date of earliest event reported
- Delaware (location) — State of incorporation
- 108 Patriot Drive, Suite A (address) — Principal executive offices
- Middletown (location) — City of principal executive offices
- 19709 (zip_code) — Zip code of principal executive offices
FAQ
What is the specific nature of the "Other Events" reported by Zymeworks Inc. on June 10, 2024?
The provided text of the 8-K filing does not specify the details of the "Other Events."
What is Zymeworks Inc.'s state of incorporation?
Zymeworks Inc. is incorporated in Delaware.
What is the address of Zymeworks Inc.'s principal executive offices?
The principal executive offices are located at 108 Patriot Drive, Suite A, Middletown, Delaware 19709.
What is Zymeworks Inc.'s telephone number?
The registrant's telephone number is (302) 274-8744.
What is the Commission File Number for Zymeworks Inc.?
The Commission File Number for Zymeworks Inc. is 001-41535.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-06-10 16:15:53
Key Financial Figures
- $0.00001 — ich registered Common Stock, par value $0.00001 per share ZYME The Nasdaq Stock Mar
- $8 million — , the Company is entitled to receive an $8 million milestone payment upon acceptance of th
Filing Documents
- d761396d8k.htm (8-K) — 23KB
- 0001193125-24-158341.txt ( ) — 137KB
- zyme-20240610.xsd (EX-101.SCH) — 2KB
- zyme-20240610_lab.xml (EX-101.LAB) — 17KB
- zyme-20240610_pre.xml (EX-101.PRE) — 11KB
- d761396d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ZYMEWORKS INC. (Registrant) Date: June 10, 2024 By: /s/ Kenneth Galbraith Name: Kenneth Galbraith Title: Chair, President, Chief Executive Officer and interim Chief Financial Officer 3